IFF Reports Third Quarter 2026 Results

IFF reported Q3 2026 results with sales of $1.94B, up 4% YoY. Adjusted operating EBITDA rose 6% to $403M. EPS was $(0.50). The company raised its full-year guidance. CEO Erik Fyrwald noted strong performance in Taste and Scent, but softer profitability expected in Q4. Cash flow for the first nine months was $245M, up $820M YoY. The company plans to complete a food ingredients divestiture by Q2 2027.

Original reporting
Published Nov 3, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$IFF
Bearish
high confidence
Mentioned
$IFF
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$IFFBearishHigh
01

Why it matters

The earnings beat and guidance lift are likely to generate buying interest, though margin pressure in certain segments tempers enthusiasm.

02

Market read

The earnings release provides fresh material for traders to position ahead of the post‑market reaction and upcoming webcast.

03

What to watch

Higher costs in Health & Biosciences and a pending Food Ingredients divestiture could pressure margins later in the year.

Relevance 8/10Novelty 9/10Timing: post‑earnings release, immediate market reaction

Background

IFF is a leading global producer of flavors and fragrances, reporting its third‑quarter 2026 results and updating its full‑year outlook.

Company-level read

Ticker impact

$IFFBearishHigh confidence
Context

IFF reported Q3 2026 results with sales up 4% YoY, adjusted EBITDA loss of $134M, and raised the low end of its full‑year guidance.

Expected impact

likely upward pressure as the market prices in the raised guidance and strong cash flow.

Evidence & confidence

The company delivered better‑than‑expected sales and lifted guidance, which typically supports a price rally.

Market effects

Strong performance may boost sentiment in the flavors & fragrances sector and related consumer‑goods stocks.

Positive for U.S. consumer discretionary and specialty chemicals markets.

Limited to companies with exposure to IFF's product lines; no broad macro effect.

Counterpoint

Guidance raise is modest and profitability remains weak; investors may stay cautious on near‑term earnings quality.

Key entities

  • Erik Fyrwald

    CEO of IFF, quoted on the results and outlook.

Related articles

$IFFHigh

BofA downgrades International Flavors & Fragrances stock rating on valuation concerns

BofA downgraded International Flavors & Fragrances (IFF) to Underperform, lowering its price target to $91. IFF reported Q3 adjusted EBITDA of $403M, beating estimates. Despite strong results, BofA cited valuation concerns, softness in non-Taste businesses, and rising costs. IFF's stock declined post-earnings due to near-term margin concerns, though management raised full-year guidance.

$IFFHighAI 8/10

Intl Flavors (IFF) Q3 2026 Earnings Call Transcript

Intl Flavors (IFF) reported Q3 2026 earnings with 5% revenue growth and 6% EBITDA increase, driven by strong performances in taste and scent segments. The company raised its full-year guidance, completed a $500M share repurchase, and announced strategic divestitures, including the sale of its food ingredients business for $4.3B. Free cash flow rose to $371M, up $245M YoY. IFF expects near-term softness in Health & Biosciences but remains confident in its growth strategy.

$IFFMedAI 9/10

IFF Q3 2026 slides: solid growth tempered by margin headwinds

International Flavors & Fragrances (IFF) reported Q3 2026 earnings with revenue of $1.94B and adjusted EPS of $0.83, beating expectations. Shares fell 3.83% due to margin concerns and guidance for softer Q4 profitability. IFF highlighted growth in Taste, Scent, and Health & Biosciences segments, along with a $4.3B sale of its Food Ingredients business and a $2.5B capital return program. Free cash flow improved to $371M, up $245M YoY.

$IFFHighAI 8/10

Key facts: IFF Beats Q3; Raises Outlook, Completes Buyback

IFF reported Q3 2026 sales of $1.942B, up 4% YoY, and adjusted EBITDA of $403M, up 5%. The company raised its 2026 sales and EBITDA outlooks but warned of lower Q4 profitability. IFF completed a $500M share buyback and plans to separate its Food Ingredients business by Q2 2027. Analysts' average 12-month price target is $98.25, implying 7% upside.

$IFFHighAI 8/10

IFF shares fall on soft 2026 guidance despite Q3 beat

International Flavors & Fragrances (IFF) beat Q3 earnings and revenue estimates, but shares fell 3% after-hours due to disappointing 2026 guidance. IFF raised its full-year revenue guidance to $7.5B-$7.6B, below analyst consensus of $7.589B. Adjusted EBITDA guidance was also raised. CEO Erik Fyrwald highlighted strong cash flow and completed a $500M share repurchase program.